Detalhe da pesquisa
1.
A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents.
Diabetes Obes Metab
; 20(1): 60-68, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28598027
2.
Improved microRNA quantification in total RNA from clinical samples.
Methods
; 50(4): S6-9, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20215018
3.
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.
Neuron
; 51(4): 417-29, 2006 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-16908408
4.
Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
Mol Pharmacol
; 74(4): 1101-8, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18617632
5.
Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions.
J Neurosci
; 24(31): 7024-36, 2004 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-15295038
6.
Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching.
Biochemistry
; 46(37): 10484-97, 2007 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-17711354
7.
Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.
J Biol Chem
; 280(44): 36926-34, 2005 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-16107343